Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy
Diseases of the Esophagus · 2026
DOI: 10.1093/dote/doag010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2026. Verfasst von Chia Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Esophagectomy, Thoracic Duct, Esophageal Neoplasms, Chylothorax. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Thoracic duct obliteration (TDO), either ligation or resection, is performed during esophagectomy to enhance oncological radicality or manage chylothorax. However, its nutritional and oncological effects are unclear. We retrospectively analyzed patients undergoing esophagectomy for esophageal cancer at our institution between January 2016 and May 2024. We assessed laboratory parameters and computed tomography-derived body composition indices from diagnosis to 9–12 months postoperatively (15–25 months for laboratory data). We also analyzed nutritional indices, overall survival (OS), and recurrence-free survival (RFS). A total of 82 patients underwent TDO, and 313 did not (non-TDO). After propensity score matching, we included 75 TDO and 150 non-TDO patients. The TDO group achieved a higher lymph node yield, without affecting chylothorax incidence, nutritional or body composition indices, OS, RFS, or recurrence patterns between the TDO and non-TDO groups. However, analysis of neoadjuvant therapy (NAT) subgroup found more subcutaneous fat loss 3–6 months postoperatively in TDO patients (−55.35% vs. −32.93%, P = 0.002). This difference was no longer evident at 9–12 months (−42.97% vs. −42.89%, P = 0.859). Among the NAT patients, thoracic duct resection was associated with better OS and RFS than non-resection (3-year OS: 77.15% vs. 57.25%, P = 0.038; 3-year RFS: 72.41% vs. 48.08%, P = 0.049). In conclusion, TDO during esophagectomy does not compromise long-term nutritional or oncological outcomes in patients with esophageal cancer. In the NAT subgroup, transient subcutaneous fat loss was evident during the early postoperative period but was no longer apparent after a year. Survival outcomes were better among NAT patients who received thoracic duct resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan.
ORCID-Profile: Chia Liu, Chien-Sheng Huang, Po-Kuei Hsu
Zitieren
APA
Liu, C., Lee, Y. Y., Chien, L. I., Tao, Z. X., Huang, C. S., Hsu, H. S., Hsu, W. H., & Hsu, P. K. (2026). Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy. Diseases of the Esophagus. https://doi.org/10.1093/dote/doag010
Vancouver
Liu C, Lee YY, Chien LI, Tao ZX, Huang CS, Hsu HS, et al. Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy. Diseases of the Esophagus. 2026. doi:10.1093/dote/doag010
BibTeX
@article{Liu2026,
author = {Liu, Chia and Lee, Yi-Ying and Chien, Ling-I and Tao, Zi-Xuan and Huang, Chien-Sheng and Hsu, Han-Shui and Hsu, Wen-Hu and Hsu, Po-Kuei},
title = {Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy},
journal = {Diseases of the Esophagus},
year = {2026},
doi = {10.1093/dote/doag010}
}
EUVIMED